Minimal change disease: A review

被引:21
|
作者
Saha, Tapasi C. [1 ]
Singh, Harmeet [1 ]
机构
[1] E Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA
关键词
minimal change disease; nephrotic syndrome; proteinuria;
D O I
10.1097/01.smj.0000243183.87381.c2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Minimal change disease (MCD) is a histopathological lesion in the kidney that is most commonly associated with nephrotic syndrome. The majority of the cases are idiopathic. Pathogenesis is not well understood, although T-cell-related mechanisms are implicated. Massive proteinuria leads to hypoalbuminemia, salt retention, disorder of hemostasis, hyperlipidemia and increased susceptibility to infections. Renal biopsy remains the gold standard for diagnosis. MCD is highly responsive to corticosteroids. Other immunosuppressive agents such as cyclophosphamide, cyclosporin, azathioprine and mycophenolate mofetil have been used to treat cases which are resistant to steroids.
引用
收藏
页码:1264 / 1270
页数:7
相关论文
共 50 条
  • [21] The diagnosis of minimal change disease in diabetic nephropathy
    Stokes, M. Barry
    THESCIENTIFICWORLDJOURNAL, 2005, 5 : 828 - 833
  • [22] Minimal Change Disease in an Adult: A Case Report
    Neupane, Shashank
    Pudasaini, Prasamsa
    Sharma, Anupam
    Sharma, Shriya
    Adhikari, Aakriti
    Roka, Kumar
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2022, 60 (248) : 399 - 401
  • [23] Systemic mastocytosis associated with minimal change disease
    Amin, Tony
    Elias, Tony
    Otto, Sophia
    Hamilton, Juliette
    AUSTRALASIAN MEDICAL JOURNAL, 2016, 9 (07): : 215 - 220
  • [24] Portal Vein Thrombosis in Minimal Change Disease
    Kim, Gyuri
    Lee, Jung Yeon
    Heo, Su Jin
    Kee, Yoen Kyung
    Han, Seung Hyeok
    EWHA MEDICAL JOURNAL, 2014, 37 (02): : 131 - 135
  • [25] Minimal-change disease secondary to etanercept
    Koya, Mariko
    Pichler, Raimund
    Jefferson, J. Ashley
    CLINICAL KIDNEY JOURNAL, 2012, 5 (05): : 420 - 423
  • [26] Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease
    Li, Xiao-Wei
    Liang, Shao-Shan
    Le, Wei-Bo
    Cheng, Shui-Qin
    Zeng, Cai-Hong
    Wang, Jin-Quan
    Liu, Zhi-Hong
    JOURNAL OF NEPHROLOGY, 2016, 29 (04) : 567 - 573
  • [27] Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine
    Hanna, Jessica
    Ingram, Alistair
    Shao, Tiffany
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
  • [28] Minimal change glomerular disease associated with solid neoplasms: a systematic review
    Cozzo, Domenico
    Orlando, Francesca
    Bruno, Mariolina
    Ogna, Adam
    Ogna, Valentina Forni
    JOURNAL OF NEPHROLOGY, 2025, 38 (02) : 343 - 352
  • [29] Minimal Change Disease and Lenalidomide
    Jamme, Matthieu
    Galichon, Pierre
    Hertig, Alexandre
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (04) : 844 - 844
  • [30] Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?
    Westhoff, TH
    Waldherr, R
    Loddenkemper, C
    Ries, W
    Zidek, W
    van der Giet, M
    CLINICAL NEPHROLOGY, 2006, 65 (03) : 203 - 207